Introduction

Chronic inflammatory process atherosclerosis plays an important role in both initiation and progression of coronary and peripheral artery atherosclerosis.1 The genesis of the atherosclerotic plaque depends on interaction of cellular components of the immune system such as cytokines and cell adhesion molecules, with lipids, platelets, and endothelial cells.

Tumour necrosis factor alpha (TNF-α) is a proinflammatory cytokine,2,3 mainly produced by monocytes, macrophages,4 and by T and B lymphocytes.5,6 TNF-α plasma concentrations increase in patients affected with premature coronary artery disease7 and is involved in obesity and insulin resistance.8,9 Its expression is regulated at the transcriptional level.10 Recently, a polymorphism affecting TNF-α transcription has been identified in the promoter region of the gene, at nucleotide position −308.11 Padovani et al12 have shown that this polymorphism may increase the risk of myocardial infarction (MI) in obese subjects. Moreover, Collins et al13 have found a significant association between Alzheimer's disease (AD) and a haplotype that included the −308 polymorphism and the TNF-α −238G/A polymorphism, in addition to a significant association involving solely the −238 polymorphism.

Interleukin-6 (IL-6) is a circulating cytokine secreted by activated macrophages and lymphocytes.14 Adipose tissue produces up to 30% of its total circulating concentration in healthy subjects.14,15 Circulating levels of IL-6 are elevated in coronary heart disease.16,17 Fishman et al,18 have identified a G/C polymorphism at nucleotide –174 within the promoter of IL-6 gene that could modify its expression. This polymorphism may also contribute to the susceptibility to type I diabetes19,20 and lipid abnormality.21 Another potentially functional IL-6 polymorphism (−572G/C) has been recently identified.22

Biological and genetic variations of TNF-α and IL-6 have never been defined in a healthy family population including children. Therefore, the objective of this study realised in such a population was to identify the factors affecting biological variation of these two molecules, to study their familial resemblance, and also to search for associations between their gene polymorphisms and the expression of the corresponding proteins.

Methods and materials

Subjects and data collection

The studied population was a sample of the STANISLAS cohort, a longitudinal family study previously described,23 designed to investigate factors related to cardiovascular disease. Participants were Caucasian and came from the Vosges and the South of Meurthe-et-Moselle (Eastern part of France). The members of the 171 families selected were apparently in good health, not under lipid-lowering and/or cardiovascular drug treatment and free from known serious and/or chronic illnesses; no one demonstrated clinical, biochemical or haematological proof of cardiovascular, hepatic or renal failure. Each subject gave a written informed consent for participating in this study, which was approved by the Local Ethics Committee.

The data collection included measurements of basic blood constituents, physical examination and medical history. Information on drug intake (notably anti-inflammatory drugs, oral contraceptives), assessing smoking status and alcohol consumption, were obtained.

Blood sample and analysis

Blood samples were collected after an overnight fast, in the morning between 9 and 10 h. Serum and plasma samples were separated by centrifugation at 2000 g for 15 min. Serum cholesterol and triglyceride (TG) levels were measured using standard enzymatic methods (Merck, Darmstadt, Germany) on an automated analyser AU5021 (Olympus, Japan), and serum HDL-C was assessed after precipitation of apolipoprotein B-containing particles by phosphotungstic acid-MgCl2 on a Cobas-Mira (Roche Diagnostic systems, France).

Blood samples for TNF-α and IL-6 were treated within 2 h (centrifugation within 1 h, and freezing (liquid nitrogen) within 2 h after blood was collected), and circulating plasma levels of IL-6 and TNF-α were measured by a commercially available enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Abington, UK). The intra-assay coefficient of IL-6 and TNF-α variations was 7.0% and the inter-assay coefficients were 14.0 and 13.0% respectively. Body mass index (BMI) was calculated according to Quetelet's formula: weight (kg)/height (m2). The genotyping of individuals for the TNF-α −308G/A, TNF-α −238G/A, IL-6 −174 G/C and IL-6 −572 G/C polymorphisms was performed using a multiplex assay, as described previously.24

Statistical analysis

Data for IL-6, TNF-α and HDL-cholesterol were log-transformed before statistical analysis to reduce the skewness of the distributions. Statistical analysis was performed with SAS software (SAS Institute Inc., USA). As individuals within a family are not independent, statistical analyses were based on the generalised estimating equation (GEE) technique,25 using the SAS GENMOD procedure with a repeated statement. Multiple regression analysis was used to determine factors of biological variation of TNF-α and IL-6 concentrations in each group of relatives (fathers, mothers, sons and daughters). The following parameters have been tested as confounding variables: age, BMI, white blood cells, tobacco and alcohol consumption, anti-inflammatory and contraceptive drug intake, and HDL-cholesterol. Family correlations for TNF-α and IL-6 concentrations were estimated by the GEE technique.26

Hardy-Weinberg equilibrium was tested for the studied polymorphisms by a chi-square test (χ2). Linkage disequilibrium between pairs of loci was tested by the Arlequin software. Associations between TNF-α polymorphisms (−308G/A and −238G/A) and TNF-α circulating levels, and between IL-6 polymorphisms (−572G/C and −174G/C) and IL-6 circulating levels were tested using the SAS GENMOD procedure. Due to the small number of individuals homozygous for the less frequent allele, homozygotes have been pooled with the corresponding heterozygotes for the statistical analysis. Statistical significance was set at P<0.05. For multiple correlations Bonferroni correction was applied and significance was set at P0.01.

Results

General characteristics of the studied population are given in Table 1. IL-6 showed a strong and positive correlation with TNF-α (data not shown).

Table 1 Characteristics of the population

Biological determinants of IL-6

Factors of biological variation of IL-6 concentration were gender, age, BMI, tobacco, white blood cells and HDL-cholesterol concentration. In the overall population, sons had lower IL-6 concentrations than fathers (P=0.01), whereas IL-6 concentrations were higher in daughters than in mothers (P=0.046). Fathers had higher IL-6 concentrations than mothers, but no statistical difference was observed between sons and daughters (Table 1).

Figure 1a shows the variation of IL-6 concentrations according to age. In offspring, IL-6 concentrations decreased significantly with age in both genders (P=0.02). Over age 20 years old, IL-6 levels in offspring reached those of the youngest parents (45 years). Then IL-6 concentrations increased with age in parents (P=0.025). These two statistical differences were obtained with monoparametric analysis. In a second step, independent determinants of IL-6 plasma concentrations in parents and offspring were searched using a multiparametric analysis (Table 2). In this case, age was not found not to be a determinant. White blood cell (WBC) number was significantly associated with increased IL-6 concentrations in sons (P0.001). Tobacco consumption was significantly related to IL-6 concentrations in fathers only (P0.01). HDL-cholesterol concentration showed a significant negative relationship with IL-6 concentrations in daughters (P0.01).

Figure 1
figure 1

(a) Variation of IL-6 according to age and sex. Data are presented as the log of values+standard error. (b) Variation of TNF-α according to age and sex. Data are presented as the log of values+standard error.

Table 2 Determinants of circulating IL-6 concentrations in parents and offspring

The main factor for IL-6 variation was: tobacco in fathers (R2=9.1%), HDL-cholesterol in daughters (R2=4%) and WBC in sons (R2=8.7%).

Biological determinants of TNF-α

Biological determinants of TNF-α concentration were tobacco in fathers, age in mothers and in children. TNF-α levels were significantly higher in offspring than in parents, (P0.001 in males and in females). No difference according to gender was observed (Table 1). Figure 1b shows the variation of TNF-α concentrations according to age. In offspring, TNF-α concentration decreased considerably (from 3.75 to 1.40) with age (P<0.001). In parents, no significant variation of TNF-α levels with age was observed. Independent determinants of TNF-α plasma concentrations in parents and offspring are presented in Table 3. Tobacco consumption was significantly and negatively associated with TNF-α levels in fathers only (P0.01). The total percentage of TNF-α variation explained by age in offspring was 3.8 and 6% in sons and daughters, respectively. In fathers, tobacco consumption explained 5.7% of the variability of TNF-α level.

Table 3 Determinants of circulating TNF-α concentrations in parents and offspring.

Familial correlations for IL-6 and TNF-α concentrations

Familial correlations of TNF-α and IL-6 are presented in Tables 4 and 5, respectively. A significant familial correlation of TNF-α levels was observed only between offspring (ρ=0.182 (0.07–0.29), P<0.01) (Table 4). The three familial correlation coefficients were significantly different (χ2=8.65 with 2 df, P<0.05). These results were not modified after adjustment for TNF-α covariates (Table 4, model 2). No significant familial correlation was observed for IL-6 concentration before and after adjustment for IL-6 covariates (Table 5).

Table 4 Familial correlations for TNF-α concentrations
Table 5 Familial correlations for IL-6 concentrations

Relations between TNF-α polymorphisms and TNF-α concentration

The −308G/A and −238G/A TNF-α genotype distributions did not differ from that expected by the Hardy–Weinberg equilibrium (Table 6). The frequency of the TNF-α −308A allele was 0.104 and that of the TNF-α −238A allele was 0.063. The two loci were in linkage disequilibrium (χ2=5.59, P=0.018). In the overall population, individuals bearing the TNF-α −308GG genotypes tended to have higher TNF-α levels than carriers of the A allele (P=0.06) (Table 7). In fact, the TNF-α −308 G/A polymorphism was associated with decreased TNF-α concentrations in the offspring aged less than 18 years (P=0.04). A significant interaction between the −308G/A TNF-α polymorphism and BMI was observed in males on TNF-α levels (P=0.031 after adjustment for covariates in each family relative). TNF-α decreased in males with BMI in individuals with the GG genotype (β=−0.019±0.009, P<0.05), whereas no significant relationship was observed in the A allele carriers (β=0.022±0.015, P<0.20). Consequently, the GG genotype was related to higher TNF-α levels in normal weight male subjects (BMI<25 kg/m2) (P=0.0045), whereas no significant effect was observed in overweight male subjects (BMI25 kg/m2) (P=0.27) (Table 8). The −308G/A TNF-α polymorphism explained 3.5% of the TNF-α level in men whose BMI was below 25 kg/m2.

Table 6 TNF-α −308 G/A, TNF-α −238G/A, IL-6 −174G/C and IL-6 −572G/C genotypes distributions
Table 7 Association between −308 G/A TNF-α polymorphism and TNF-α circulating levels
Table 8 Association between −308 G/A TNF-α polymorphism and TNF-α levels according to BMI in males

Relations between IL-6 polymorphisms and IL-6 concentration

The IL-6 −572G/C and IL-6 −174G/C genotypes distributions are presented in Table 6. They did not differ from that expected by the Hardy–Weinberg equilibrium. The frequency of the −572C allele was 0.053 and that of the −174C allele was 0.395. The two loci were in linkage disequilibrium (χ2=24.97, P<0.001), the −572CC genotype being more frequently associated with the −174GG genotype.

A relationship between IL-6 levels and −174G/C polymorphism was only observed in fathers (P=0.018, 1% of explained variation) and a relationship between IL-6 levels and −572G/C polymorphism was found in both parents (P=0.026, 1.22% of explained variation) (Table 9). Fathers with the −174CC genotype had higher IL-6 levels than those with the −174G allele and parents with the −572GG genotype had higher IL-6 concentrations than carriers of the C allele.

Table 9 Association between –572G/C, –174G/C IL-6 polymorphisms and IL-6 concentration

Discussion

Biological and genetic determinants of plasma TNF-α and IL-6 concentrations have been investigated in a healthy family-based population. Gender, age, tobacco consumption, BMI, WBC and HDL-C influenced differently IL-6 and TNF-α concentrations. Contrary to TNF-α, plasma IL-6 levels were significantly different according to gender. However, previous studies did not find sex effect on IL-6.27

TNF-α concentrations decreased with age in both genders for offspring. After a multi-parameter analysis, age was shown to be a determinant of TNF-α circulation level in offspring only (both sons and daughters). However, age was not a determinant of IL-6 level in any group (father, mother, sons or daughters). This is the first study on the variations of IL-6 and TNF-α levels with age, including children and middle-aged subjects (from 5 to 56 years). An other study was realised with children only, aged from 3 to 17 years old, but no statistical analysis was performed.28 In the present study, a continuous decrease was observed in TNF-α between 5 and 17 years, whereas Sack et al28 found an increase in TNF-α level between 5 and 10 years and, and a decrease between 10 and 15 years. However, TNF-α concentrations were very high in some subjects (around 100 pg/ml). In the literature, other studies concern populations aged from more than 15 years old. They also include adults in their statistics, and the effects of age are given by correlation coefficients in the entire population, without taking into account the effect of other parameters. In the present familial study, parents were studied independently of children. Moreover, not only coefficient of regression calculations but also multiparametric searches were done for determination of variations. Generally, other studies give an increase of IL-6 after adolescence.27,29,30,31 Few informations exist on the variation of TNF-α. Values could increase in women.31 We only found variations in offspring. Metabolic pathways underlying the age-related variation in IL-6 are still under investigation.27 Effect of puberty and menopause have been checked in our study. No effect has been proved to be significant.

Smoking was associated with IL-6 and TNF-α concentrations in fathers only. No relation was observed in mothers and offspring probably because of the modest tobacco consumption. The fact that IL-6 was positively correlated to tobacco consumption is in agreement with previous studies.32,33 TNF-α and tobacco consumption were negatively related. Recent studies in healthy men showed that smoking status had no effect on TNF-α concentrations.32,34 Macrophage cells secrete more TNF-α in the presence of lower concentrations of smokeless tobacco than in the presence of higher concentrations.35 Vayssier et al36 also observed, as we did, that tobacco was related with decreased TNF-α concentrations, and concluded that it could abolish TNF-α cellular release.

BMI was not associated with IL-6 or TNF-α. Numerous contradictory reports exist in the literature.27,37,38,39

Familial factors appear to have a modest impact on TNF-α and IL-6 levels, as no significant familial correlation for IL-6 and a small one were observed for TNF-α in offspring. However, genetic variants in TNF-α and IL-6 genes could affect their respective gene product concentration with modulation by the context (ie gender, age and BMI).

IL-6 and TNF-α familial resemblances are in contradiction with those of Pantsulaia et al27 who showed a strong familial resemblance especially for IL-6 (heritability about 80%) and about 24% for TNF-α. The only difference in methodology is that, in our study, plasma was stored in liquid nitrogen before analysis. In the Pantsulaia study, samples were kept frozen at −80°C instead of liquid nitrogen. The discrepancy may be due to the different origins and ages of the two populations. This last population, aged from 18 to 75 years, was collected from small villages (Russian federation). The impact of genetic and/or environmental factors may be more important in such isolated populations.

The relationship between TNF-α –308G/A polymorphism and TNF-α levels was dependent on age and BMI. The TNF-α –308A allele was related to decreased TNF-α levels in offspring (age≤18 years) and in normal-weight male subjects (BMI<25 kg/m2). Overweight may be not sufficient to produce a significant effect on the relation between the genotype and TNF-α levels, and to observe increased TNF-α levels with the A allele in overweight subjects. This is in agreement with the fact that obesity can induce an inappropriate secretion of IL-6 and TNF-α.40,41

No relation was observed between the TNF-α −238G/A polymorphism and TNF-α level. Contradictory results may be found in the literature: both an increase41,42,43 and a decrease44 in TNF-α protein expression can be associated with the −238A allele.

Men with the −174CC genotype and adults with the −572GG genotype had higher IL-6 levels, the two genotypes being in linkage disequilibrium. This association between −174C allele and higher levels of plasma IL-6 is supported by another study of patients with aneurysmal disease, where subjects with the C allele had higher IL-6 levels and higher mortality.45 However, Fishman et al18 found that the C allele was associated with lower IL-6 levels in a small group of healthy men and women aged from 40 to 75 years old. The −174 G/C polymorphism could exhibit different effects in individuals older than those included in the present study (men 38–56 years old). Our results are in agreement with Brull et al,46 who found the C allele related to increased IL-6 levels in patients after coronary artery bypass. Consistent with these findings, the C allele was associated positively with C-reactive protein (CRP),47,48 and IL-6 was reported as the primary determinant of the hepatic production of CRP.49 In addition, the C allele was more common in men affected with MI than in controls50 and IL-6 was found elevated in coronary heart disease patients.16,17

The newly identified –572G/C IL-6 polymorphism22 is still less studied than the −174G/C IL-6 polymorphism. For the first time, in a healthy population, a relationship has been shown between this polymorphism and IL-6 levels, the adults with the −572GG genotype having an increased IL-6 level compared with the carriers of the C allele. Brull et al46 showed that the IL-6 –572C allele was related to increased Il-6 levels in patients after coronary artery bypass, whereas Humphries et al51 found that the IL-6 −572G/C polymorphism was not associated with CHD risk in healthy men.

Conclusion

In conclusion, we have determined, for the first time, the main biological factors affecting IL-6 and TNF-α concentrations in a healthy family population including children. We have also shown genetic influences on TNF-α and IL-6 plasma concentrations involving environmental factors. Two of them are of particular interest as they could concern the risk of cardiovascular disease, although this is in debate. If this is confirmed, it could help in the prevention of this pathology.